bioRxiv · 10.64898/2026.11.01.763250
NAD Metabolism Drives CTCF-Cohesin Chromatin Regulation in EBV-Transformed B-Cells
Abstract
Chromatin architecture regulates gene expression, and it is maintained by architectural proteins such as CTCF and the cohesin complex. In Epstein Barr virus infected cells, viral chromatin organization is stabilized through the interaction between PARP1 and CTCF, ensuring maintenance of latent gene expression. EBV B cells exhibit elevated PARP1 activity, which imposes a substantial metabolic burden due to NAD consumption by PARP1 itself. We demonstrate that efficient EBV infection and B-cell transformation rely on the NAD salvage pathway to sustain PARP1 activity and CTCF and cohesin chromatin folding. Pharmacologic inhibition of the rate-limiting enzyme NAMPT with FK866 phenocopies the chromatin architectural disruption induced by PARP1 and changes in NAD levels affects CTCF/cohesin chromatin architectural remodeling and loop extrusion. Moreover, NAMPT inhibition reduces tumor burden in EBV xenograft models. These findings identify a critical metabolic dependency linking NAD homeostasis to CTCF-cohesin mediated chromatin architecture and reveal a therapeutic vulnerability in EBV-associated malignancies.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Maestri, D., Sklutuis, R., Caruso, L. B., Preston-Alp, S., Gatto, M., Soldan, S. S., Park, P., Melick, L., Corveleyn, L., Sidoli, S., Kossenkov, A., Goldman, A. R., Zhang, W., Tang, H.-Y., Napoletani, G., Liao, Y., Lieberman, P. M., Gewurz, B. E., Tempera, I.. 2026-11-02. NAD Metabolism Drives CTCF-Cohesin Chromatin Regulation in EBV-Transformed B-Cells. https://doi.org/10.64898/2026.11.01.763250
Cite the original work for its findings. Save a collection to share your selection of sources.